Altria Group, Inc.
- Open
- 73.90
- Day high
- 74.14
- Day low
- 73.14
- Prev close
- 73.79
- Volume
- 5.1M
- Mkt cap
- $120.5B
- P/E (TTM)
- 15.1
- EPS (TTM)
- $4.91
- P/B
- -37.5
- P/S
- 5.5
- Yield
- 5.88%
- Per share
- $4.24
- ▼Insiders net selling -$563K over the last 3 months (0 open-market buys, 2 sales)
- 🏛Institutions accumulating (13F)
Altria Group, Inc. (MO) is a Consumer Defensive company listed on NYSE. The stock is up 24% over the past year. Over the trailing 3 months, insiders filed 0 open-market buys and 2 sales (SEC Form 4).
Altria Group, Inc. (MO) financials & analyst ratings
Fundamentals (TTM)
Analyst consensus · 4 analysts
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
MO earnings date, history & EPS estimates
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Apr 30, 2026 | $1.25 | $1.32 | +5.6% | $4.8B | +3.9% |
| Jan 29, 2026 | $1.32 | $1.30 | -1.5% | $5.8B | +16.2% |
| Oct 30, 2025 | $1.44 | $1.45 | +0.7% | $5.3B | -0.8% |
| Jul 30, 2025 | $1.39 | $1.44 | +3.6% | $5.3B | +1.9% |
| Jan 30, 2025 | $1.28 | $1.29 | +0.8% | $5.1B | +1.2% |
| Oct 31, 2024 | $1.35 | $1.38 | +2.2% | $5.3B | +0.3% |
| Jul 31, 2024 | $1.34 | $1.31 | -2.2% | $5.3B | -2.1% |
| Apr 25, 2024 | $1.15 | $1.15 | +0.0% | $4.7B | +0.1% |
| Feb 1, 2024 | $1.17 | $1.18 | +0.9% | $5.0B | +7.7% |
| Oct 26, 2023 | $1.29 | $1.28 | -0.8% | $5.3B | +3.1% |
| Aug 1, 2023 | $1.30 | $1.31 | +0.8% | $5.4B | +0.2% |
| Apr 27, 2023 | $1.18 | $1.18 | +0.0% | $4.8B | -2.9% |
MO insider trading activity (SEC Form 4)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 28, 2026 | Strahlman Ellen Rdirector | Sell | 2,000 | $72.56 |
| May 28, 2026 | KELLY ENNIS DEBRA Jdirector | Sell | 5,790 | $72.25 |
| May 18, 2026 | Connelly Marjorie Marydirector | Grant | 2,571 | — |
| May 18, 2026 | YZAGUIRRE MARIO MAXdirector | Grant | 2,571 | — |
| May 18, 2026 | Stoddart Richard Sdirector | Grant | 2,571 | — |
| May 18, 2026 | Strahlman Ellen Rdirector | Grant | 2,571 | — |
| May 18, 2026 | KELLY ENNIS DEBRA Jdirector | Grant | 2,571 | — |
| May 18, 2026 | SHANKS VIRGINIA Edirector | Grant | 2,571 | — |
| May 18, 2026 | McQUADE KATHRYN B.director | Grant | 4,656 | — |
| May 18, 2026 | Davis Robert Matthewsdirector | Grant | 2,571 | — |
| May 18, 2026 | Clarke Ian L.T.director | Grant | 2,571 | — |
| May 15, 2026 | Mancuso Salvatoredirector, officer: Chief Executive Officer | Grant | 40,634 | — |
| Mar 9, 2026 | Whitaker Charles N.officer: SVP, Chief HR Off. & CCO | Sell | 27,908 | $67.57 |
| Mar 2, 2026 | Begley Jody Lofficer: EVP and COO | Tax | 17,439 | $69.70 |
| Mar 2, 2026 | McCarter Robert A. IIIofficer: EVP & General Counsel | Tax | 4,517 | $69.70 |
Source: MO SEC Form 4 filings, latest May 28, 2026. For informational purposes only — not investment advice.
See the full MO insider & 13F page →Altria Group, Inc. company profile
Overview
Altria Group, Inc. (NYSE:MO) is one of America's largest tobacco companies, tracing its origins back to 1822 when Philip Morris was founded in London as a tobacco shop. The company established its American operations in 1902 and grew to become the dominant force in the U.S. cigarette market through aggressive marketing and brand building, particularly with its flagship Marlboro brand. After decades of expansion and diversification into various consumer products, Altria spun off its international tobacco operations in 2008 and food businesses to focus exclusively on the U.S. tobacco market. Today, the company operates as a holding company based in Richmond, Virginia, controlling some of the most recognizable tobacco brands in America while simultaneously investing in smoke-free alternatives as traditional cigarette consumption continues to decline.
Business
Altria operates in the tobacco industry, which involves the cultivation, processing, manufacturing, and distribution of tobacco products for consumer consumption. The tobacco industry has been a mature, heavily regulated sector that generates substantial cash flows despite declining consumption trends due to health concerns and regulatory pressures. The company operates through two primary business segments that generate the vast majority of its revenue: 1. **Smokeable Products Segment** (approximately 85-90% of revenue): This segment manufactures and sells cigarettes, cigars, and pipe tobacco. The crown jewel is the Marlboro cigarette brand, which commands a dominant 42% share of the U.S. retail cigarette market and maintains premium pricing power. Cigarettes are combustible tobacco products wrapped in paper that consumers light and smoke. The segment also includes Black & Mild cigars and various pipe tobacco products. This segment generates exceptional profit margins, typically exceeding 60%, due to brand loyalty, pricing power, and economies of scale. 2. **Oral Tobacco Products Segment** (approximately 10-15% of revenue): This segment produces smokeless tobacco products that consumers place in their mouth rather than smoke. Traditional products include moist smokeless tobacco under brands like Copenhagen, Skoal, Red Seal, and Husky. The segment has been expanding into modern oral nicotine products, particularly on! nicotine pouches, which are small pouches containing nicotine that users place between their lip and gum. These products appeal to consumers seeking nicotine without the combustion associated with cigarettes. The company has also been investing in emerging smoke-free categories, including e-vapor products through its NJOY brand acquisition and heated tobacco products through a joint venture with Japan Tobacco. These investments represent Altria's strategic pivot toward reduced-risk products as traditional cigarette consumption declines by approximately 10% annually.
Revenue model
Altria generates revenue primarily through direct product sales to wholesalers, distributors, and large retail chains who then sell to consumers. The company's business model relies on several key revenue streams: **Product Sales Revenue**: The vast majority of income comes from selling manufactured tobacco products at wholesale prices. Cigarettes generate the highest absolute revenue due to volume, while oral tobacco products command premium pricing. The company benefits from significant pricing power, regularly implementing price increases that more than offset volume declines. **Licensing and Royalties**: Altria earns additional income from licensing its brands and manufacturing processes, though this represents a smaller portion of total revenue. The company's profitability is driven by several factors that can increase margins: **Brand loyalty and pricing power** allow regular price increases without proportional volume losses, as tobacco products are highly addictive and brand-switching is limited. **Economies of scale** in manufacturing and distribution create cost advantages. **Regulatory barriers** limit new entrants and protect market share. **Operational efficiency improvements** through automation and supply chain optimization reduce per-unit costs. Conversely, several factors pressure margins: **Declining consumption** due to health awareness and regulatory restrictions reduces volume. **Excise tax increases** at federal and state levels compress after-tax margins for consumers, potentially accelerating volume declines. **Litigation costs** from tobacco-related lawsuits create ongoing financial burdens. **Regulatory compliance costs** for product testing, marketing restrictions, and manufacturing standards increase operational expenses. **Competition from illicit products**, particularly in e-vapor categories, erodes market share for legal alternatives. **Economic pressure on consumers** during inflationary periods can drive trading down to discount brands or reduced consumption occasions. The company's customers are primarily wholesalers and large retail organizations rather than individual consumers, creating a B2B2C model where Altria must maintain relationships with distributors while also building consumer brand loyalty through marketing and product quality.
Competitive moat
Altria possesses several significant competitive advantages that create a substantial economic moat, though this moat faces long-term erosion due to secular industry decline and regulatory pressures. **Brand Power and Consumer Loyalty**: The company's strongest moat element is the Marlboro brand, which has maintained market leadership for decades through consistent quality and extensive marketing investment. Tobacco products create physical addiction, resulting in extremely low price elasticity and high switching costs for consumers. This addiction-driven loyalty provides exceptional pricing power and recurring revenue streams. **Regulatory Barriers**: The tobacco industry operates under extensive federal and state regulations that create high barriers to entry. New tobacco products require costly FDA approval processes, and existing players benefit from grandfathered market positions. Manufacturing facilities require significant compliance investments, and marketing restrictions favor established brands with existing consumer relationships. **Distribution Network and Scale**: Altria has built extensive relationships with wholesalers and retailers over decades, creating switching costs for distribution partners. The company's manufacturing scale provides cost advantages that smaller competitors cannot match, particularly in procurement, production efficiency, and regulatory compliance. **Cash Generation Capability**: The business model generates exceptional free cash flow due to high margins, limited capital requirements, and predictable demand patterns. This financial strength provides resources for strategic investments, shareholder returns, and weathering regulatory challenges. However, the moat faces significant threats: **Secular decline** in cigarette consumption continues at approximately 10% annually, eroding the core business foundation. **Regulatory pressure** including potential menthol bans, flavor restrictions, and taxation increases threaten profitability. **Litigation risks** create ongoing financial uncertainty. **Illicit competition**, particularly in emerging smoke-free categories, undermines legal market development. **Social stigma** and health awareness continue reducing tobacco acceptability. The company's investments in smoke-free alternatives represent attempts to build new moats in growing categories, but these efforts face intense competition from both traditional tobacco companies and new entrants, with less established brand loyalty and regulatory protection.
Risks & safety
Altria demonstrates a mixed margin of safety profile, with strong cash generation offset by high debt levels and secular industry decline. **Financial Strength**: - Strong free cash flow generation of $8.6 billion annually provides substantial financial cushion - Cash and short-term investments of $3.1 billion offer liquidity buffer - Operating cash flow of $8.8 billion demonstrates consistent cash generation capability **Debt and Solvency Concerns**: - Total liabilities of $37.4 billion exceed total assets of $35.2 billion, creating negative equity position - Debt-to-equity ratio of -7.4 indicates highly leveraged capital structure - Current ratio of 0.51 suggests potential short-term liquidity pressures - Despite high debt, strong cash flows provide debt service capability **Valuation Metrics**: - Price-to-earnings ratio of 8.0 suggests reasonable valuation relative to earnings - EV/EBITDA of 7.4 indicates moderate valuation for cash flow generation - Dividend yield exceeding 8% provides attractive income but raises sustainability questions given payout ratios **Other Considerations**: - Secular industry decline creates long-term volume pressure - Regulatory and litigation risks pose ongoing financial threats - High dividend payout ratios may not be sustainable if cash flows decline significantly - Investment in smoke-free alternatives requires continued capital allocation with uncertain returns
Recent development
Over the past several years, Altria has undertaken a significant strategic transformation focused on diversifying beyond traditional cigarettes into smoke-free alternatives while maintaining profitability from its core combustible business. **Smoke-Free Portfolio Expansion**: The company has aggressively invested in building a comprehensive smoke-free product portfolio. The acquisition of NJOY provided entry into the e-vapor category, with NJOY receiving the first FDA marketing authorization for menthol e-vapor products. The on! nicotine pouch brand has shown strong growth, expanding from minimal market presence to 8.8% category share with 44% volume growth in recent periods. Additionally, Altria formed a joint venture with Japan Tobacco to develop heated tobacco products, with plans to submit regulatory applications for the Ploom device in mid-2025. **Operational Efficiency Initiative**: Management launched the "Optimize and Accelerate" program targeting $600 million in cumulative cost savings over five years through operational modernization, automation, and supply chain optimization. This initiative reflects the company's focus on maintaining profitability despite declining cigarette volumes. **Regulatory Navigation and Market Challenges**: The company has faced significant challenges from illicit competition, particularly in e-vapor categories where an estimated 60% of products are non-compliant with FDA regulations. Altria has actively advocated for increased regulatory enforcement while working to bring authorized alternatives to market. The company also navigated patent litigation with JUUL, exploring multiple resolution pathways including settlements and product modifications. **Financial Strategy Evolution**: Altria has maintained its commitment to shareholder returns while balancing investments in growth categories. The company returned over $10 billion to shareholders in 2024 through dividends and share repurchases while continuing to invest in smoke-free product development and market expansion. **Strategic Goal Reassessment**: Management has reassessed its 2028 smoke-free revenue goals due to challenging market dynamics, particularly the prevalence of illicit products that undermine legal market development. This reflects a more realistic approach to the transition timeline while maintaining long-term commitment to tobacco harm reduction.
MO company profile · for informational purposes only — not investment advice.
Track MO with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free